Bradrick Brittany 4
4 · Dermata Therapeutics, Inc. · Filed Jan 6, 2026
Insider Transaction Report
Form 4
Bradrick Brittany
Director
Transactions
- Award
Stock Option (Right to Buy)
2026-01-02+2,500→ 2,500 totalExercise: $2.18Exp: 2036-01-01→ Common Stock (2,500 underlying)
Footnotes (1)
- [F1]The shares underlying the option will vest in a series of twelve (12) successive substantially equal monthly installments, with the first installment vesting on the one month anniversary of the grant date and continuing to vest monthly thereafter, subject to Reporting Person's continuous service through each such vesting date.